Ribomic (TSE:4591) Marketable Securities: 円900.00 Mil (As of Mar. 2026)


TSE:4591 Ribomic Inc TSE:4591
25 GF Score
Price 円74.00
! 3 Warning Signs
View Full Analysis

What is Ribomic Marketable Securities?

Ribomic TSE:4591 -3.90% 25 Marketable Securities is 円900.00 Mil as of Mar. 2026. GuruFocus rates TSE:4591 with a GF Score™ of 25/100. The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Ribomic's Marketable Securities for the quarter that ended in Mar. 2026 was 円900.00 Mil.

Ribomic's annual Marketable Securities declined from Mar. 2024 (円1,300.00 Mil) to Mar. 2025 (円1,200.00 Mil) and declined from Mar. 2025 (円1,200.00 Mil) to Mar. 2026 (円900.00 Mil).

Ribomic  (TSE:4591) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Ribomic Marketable Securities Related Terms

Ribomic Marketable Securities Historical Data

* Premium members only.

The historical data trend for Ribomic's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ribomic Marketable Securities Chart

Ribomic Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,800.00 1,500.00 1,300.00 1,200.00 900.00

Ribomic Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,300.00 1,500.00 1,200.00 1,300.00 900.00
TSE:4591
25GF Score
Ribomic Inc TSE:4591
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ribomic Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of 円900.00 Mil mean?
Ribomic (TSE:4591) has a Marketable Securities of 円900.00 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Ribomic and its competitors.
Is Ribomic's Marketable Securities too high?
Ribomic's current Marketable Securities is 円900.00 Mil. Overall, Ribomic has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Ribomic's Marketable Securities compare to VRTX and REGN?
Ribomic's Marketable Securities of 円900.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Ribomic and its competitors. Ribomic's current Marketable Securities is 円900.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ribomic stock overvalued right now?
Ribomic (TSE:4591) has a current Marketable Securities of 円900.00 Mil. The current Marketable Securities is 円900.00 Mil. Ribomic's overall GF Score™ is 25/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Ribomic (TSE:4591), the current Marketable Securities is 円900.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ribomic Business Description

Address 3-16-13 Usui Building, Shirokanedai, Minato-ku, Tokyo, JPN, 108-0071
Ribomic Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies, the RiboART System.
25GF Score

Get the complete analysis for TSE:4591

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円74.00
Price